Alnylam Pharmaceuticals, Inc.
2020 Q3 - 2025 Q4 (7 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 16,089 | 0.0% | 40,459 | 12/31/2025 |
| 2024 Q2 | 9/20/2024 | 1,153 | 0.0% | 4,744 | 6/30/2024 |
| 2023 Q2 | 8/11/2023 | 1,196 | 0.0% | 6,295 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 103 | 0.0% | 514 | 3/31/2023 |
| 2022 Q3 | 11/14/2022 | 288 | 0.0% | 1,440 | 9/30/2022 |
| 2021 Q2 | 8/12/2021 | 4 | 0.0% | 24 | 6/30/2021 |
| 2020 Q3 | 3/1/2021 | 213 | 0.0% | 1,460 | 9/30/2020 |